{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:49:15Z","timestamp":1791834555246,"version":"4.3.4"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ejmech.2026.119413","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:06:36Z","timestamp":1791558396000},"page":"119413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Coumarin-based hybrid anticancer agents: Recent advances in rational design, structure\u2013activity relationships, and biological mechanisms"],"prefix":"10.1016","volume":"321","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6550-6881","authenticated-orcid":false,"given":"Aashik","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0836-9369","authenticated-orcid":false,"given":"Md Arif","family":"Naseer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9821-6309","authenticated-orcid":false,"given":"Mayank","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7874-5167","authenticated-orcid":false,"given":"Anurag","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1325-8034","authenticated-orcid":false,"family":"Manisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3010-5611","authenticated-orcid":false,"given":"Komal","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119413_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2026.119413_bib2","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2026.119413_bib3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(22)01438-6","article-title":"The global burden of cancer attributable to risk factors, 2010\u201319: a systematic analysis for the global burden of disease study 2019","volume":"400","author":"Tran","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119413_bib4","doi-asserted-by":"crossref","DOI":"10.1200\/GO.22.00054","article-title":"Role of local evidence in transferring evidence-based interventions to low- and middle-income country settings: application to global cancer prevention and control","author":"Parascandola","year":"2022","journal-title":"JCO Glob. Oncol."},{"key":"10.1016\/j.ejmech.2026.119413_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay9040","article-title":"Early detection of cancer","volume":"375","author":"Crosby","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.119413_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12672-025-02198-8","article-title":"Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy","volume":"16","author":"Zafar","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.ejmech.2026.119413_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2026.119413_bib8","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119413_bib9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.119413_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316584","article-title":"Advance in targeted cancer therapy and mechanisms of resistance","volume":"24","author":"Tang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119413_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40169-017-0181-2","article-title":"A perspective on multi-target drug discovery and design for complex diseases","volume":"7","author":"Ramsay","year":"2018","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.119413_bib12","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.2174\/1568026619666190619115735","article-title":"Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases","volume":"19","author":"Ivasiv","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib13","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2174\/1568026616666160927155515","article-title":"Hybrid compounds as multitarget directed anticancer agents","volume":"17","author":"Kucuksayan","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib14","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00044-026-03607-5","article-title":"Indole-based derivatives as anticancer agents: recent advances in structure\u2013activity relationships and biological mechanisms","volume":"35","author":"Malik","year":"2026","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2026.119413_bib15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3390\/molecules23020250","article-title":"Coumarin: a natural, privileged and versatile scaffold for bioactive compounds","volume":"23","author":"Stefanachi","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119413_bib16","doi-asserted-by":"crossref","first-page":"31257","DOI":"10.1039\/D6RA01594H","article-title":"Coumarin hybrids as privileged therapeutic scaffolds: biological activities, mechanistic insights, and therapeutic potential","volume":"16","author":"Naeem","year":"2026","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119413_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/biom10010151","article-title":"Recent advances in the synthesis of coumarin derivatives from different starting materials","volume":"10","author":"Lon\u010dari\u0107","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2026.119413_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1002547","article-title":"A twenty-year journey exploring coumarin-based derivatives as bioactive molecules","volume":"10","author":"Pisani","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111587","article-title":"Coumarin-containing hybrids and their anticancer activities","volume":"181","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib20","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3390\/ph17070956","article-title":"Novel coumarin\u2013nucleobase hybrids with potential anticancer activity: synthesis, in vitro cell-based evaluation, and molecular docking","volume":"17","author":"Correa de Moraes","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.119413_bib21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/pharmaceutics18030341","article-title":"Coumarin-based prodrugs: therapeutic promise or still confined to preclinical exploration?","volume":"18","author":"Chavez Alvarez","year":"2026","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2026.119413_bib22","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3390\/molecules29051026","article-title":"Recent trends in the synthesis and bioactivity of coumarin, coumarin\u2013chalcone, and coumarin\u2013triazole molecular hybrids","volume":"29","author":"Rohman","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119413_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1039\/D3MD00511A","article-title":"Latest developments in coumarin-based anticancer agents: mechanism of action and structure-activity relationship studies","volume":"15","author":"Koley","year":"2023","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1570193X19666220701111051","article-title":"An update on recent green synthetic approaches to coumarins","volume":"21","author":"Bhimani","year":"2024","journal-title":"Mini-Reviews Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib25","first-page":"241","article-title":"Progress in the chemistry of naturally occurring coumarins","volume":"106","author":"Sarker","year":"2017","journal-title":"Prog. Chem. Org. Nat. Prod."},{"key":"10.1016\/j.ejmech.2026.119413_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.103654","article-title":"Recent advances in the microwave- and ultrasound-assisted green synthesis of coumarin-heterocycles","volume":"15","author":"Borah","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2025.102181","article-title":"An overview of the synthesis of coumarins via knoevenagel condensation and their biological properties","volume":"15","author":"Tchoffo Tchoupou","year":"2025","journal-title":"Results Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.22159\/ajpcr.2019.v12i3.30635","article-title":"Coumarins: a unique scaffold with versatile biological behavior","author":"Gupta","year":"2019","journal-title":"Asian J. Pharmaceut. Clin. Res."},{"key":"10.1016\/j.ejmech.2026.119413_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12039-024-02267-5","article-title":"Coumarin-3-carboxylic acid: C3\/C4-functionalizations and cyclization reactions","volume":"136","author":"Doraghi","year":"2024","journal-title":"J. Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.119413_bib30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3762\/bjoc.8.35","article-title":"Dioxane dibromide mediated bromination of substituted coumarins under solvent-free conditions","volume":"8","author":"Chaudhuri","year":"2012","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/chemistry8070093","article-title":"Coumarin derivatives as inhibitors of pathological protein aggregation, mechanistic basis of \u03b2-sheet intercalation, structure\u2013activity relationship, and multi-target therapeutic design\u2014a critical review of the computational and biophysical evidence","volume":"8","author":"Masri","year":"2026","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2026.119413_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6492346","article-title":"Natural coumarins: exploring the pharmacological complexity and underlying molecular mechanisms","volume":"2021","author":"Sharifi-Rad","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejmech.2026.119413_bib33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/14756366.2021.2024528","article-title":"Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms","volume":"37","author":"Eldehna","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib34","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.3390\/ijms21134618","article-title":"An overview of coumarin as a versatile and readily accessible scaffold with broad-ranging biological activities","volume":"21","author":"Annunziata","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119413_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105424","article-title":"An insight into the therapeutic applications of coumarin compounds and their mechanisms of action","volume":"152","author":"Garg","year":"2020","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2026.119413_bib36","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.3390\/molecules30214167","article-title":"Coumarin derivatives as anticancer agents: mechanistic landscape with an emphasis on breast cancer","volume":"30","author":"Hacholli","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119413_bib37","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3390\/biomedicines12061192","article-title":"Coumarin as an elite scaffold in anti-breast cancer drug development: design strategies, mechanistic insights, and structure\u2013activity relationships","volume":"12","author":"Singh","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2026.119413_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/fsn3.4696","article-title":"Recent perspectives on anticancer potential of coumarin against different human malignancies: an updated review","volume":"13","author":"Shahbaz","year":"2025","journal-title":"Food Sci. Nutr."},{"key":"10.1016\/j.ejmech.2026.119413_bib39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3390\/pharmaceutics17050595","article-title":"Coumarins in anticancer therapy: mechanisms of action, potential applications and research perspectives","volume":"17","author":"Navarra","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2026.119413_bib40","article-title":"Recent advances on anticancer activity of coumarin derivatives","volume":"5","author":"Rawat","year":"2022","journal-title":"Eur J Med Chem Rep"},{"key":"10.1016\/j.ejmech.2026.119413_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-50170-9","article-title":"Synthesis and in-vitro anti-proliferative with antimicrobial activity of new coumarin containing heterocycles hybrids","volume":"13","author":"Abdelaziz","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119413_bib42","doi-asserted-by":"crossref","DOI":"10.1039\/D4RA04226C","article-title":"Coumarin\u2013amino acid hybrids as promising anticancer agents: design, synthesis, docking studies and CK2 inhibition","volume":"14","author":"El-Etrawy","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119413_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000025","article-title":"Coumarin derivatives with anticancer activities: an update","volume":"353","author":"Song","year":"2020","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.ejmech.2026.119413_bib44","article-title":"Cell protection by oxidative stress mitigation using substances with bioactive properties","author":"Po\u017egajov\u00e1","year":"2024","journal-title":"Intech"},{"key":"10.1016\/j.ejmech.2026.119413_bib45","first-page":"447","article-title":"Coumarin and its derivatives: a comprehensive review of pharmacological activities","volume":"4","author":"Teli","year":"2026","journal-title":"Int J Pharm Sci"},{"key":"10.1016\/j.ejmech.2026.119413_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2174\/1568026622666220105105450","article-title":"Recent developments of coumarin-based hybrids in drug discovery","volume":"22","author":"Xia","year":"2022","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202400777","article-title":"A promising therapeutic scaffold fusing chalcone\/coumarin targeting colorectal cancer: design, synthesis, biological and ADME-tox modelling","volume":"9","author":"Ram\u00edrez-Bedoya","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2026.119413_bib48","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2174\/1385272824666200219091830","article-title":"Synthetic strategies and biological potential of coumarin-chalcone hybrids: a new dimension to drug design","volume":"24","author":"Pasricha","year":"2020","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib49","first-page":"31","article-title":"Coumarin\u2013chalcone hybrids in cancer therapy: a comprehensive review of mechanistic insights","volume":"4","author":"Taleshtabar Dolaty","year":"2026","journal-title":"Nano Micro Biosystems"},{"key":"10.1016\/j.ejmech.2026.119413_bib50","doi-asserted-by":"crossref","first-page":"960","DOI":"10.47857\/irjms.2025.v06i02.03636","article-title":"Novel coumarin chalcone derivatives: synthesis and anticancer evaluation","volume":"6","author":"Kumari","year":"2025","journal-title":"Int Res J Multidiscip Scope"},{"key":"10.1016\/j.ejmech.2026.119413_bib51","first-page":"1162","article-title":"Synthesis of novel anticancer coumarin-triazole-chalcone hybrids as potential AKT inhibitors","volume":"62","author":"Mallikarjun","year":"2023","journal-title":"Indian J. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib52","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.arabjc.2017.10.001","article-title":"Synthesis and biological evaluation of novel coumarin-chalcone derivatives containing urea moiety as potential anticancer agents","volume":"13","author":"Kurt","year":"2020","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1231450","article-title":"Natural product-inspired synthesis of coumarin\u2013chalcone hybrids as potential anti-breast cancer agents","volume":"14","author":"Alhakamy","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119413_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103530","article-title":"Design, synthesis and bioactivity evaluation of coumarin-chalcone hybrids as potential anticancer agents","volume":"95","author":"Wang","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib55","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/14756366.2022.2056734","article-title":"Novel 3-(6-methylpyridin-2-yl)coumarin-based chalcones as selective inhibitors of cancer-related carbonic anhydrases IX and XII endowed with anti-proliferative activity","volume":"37","author":"Tawfik","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib56","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/scipharm93020016","article-title":"Synthesis and biological evaluation of some coumarin\u2013triazole conjugates as potential anticancer agents","volume":"93","author":"Kishkentayeva","year":"2025","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ejmech.2026.119413_bib57","doi-asserted-by":"crossref","DOI":"10.22271\/reschem.2025.v6.i1a.165","article-title":"1,2,3-Triazole hybrids in medicinal chemistry: advances in click chemistry and cytotoxic studies","volume":"6","author":"M","year":"2025","journal-title":"J Res Chem"},{"key":"10.1016\/j.ejmech.2026.119413_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202501775","article-title":"Design, synthesis, and molecular docking of triazole-coumarin hybrids as potent breast cancer inhibitors targeting cell cycle and apoptosis","volume":"22","author":"Keser","year":"2025","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2026.119413_bib59","article-title":"Novel 1,2,3-triazole-coumarin hybrid glycosides and their tetrazolyl analogues: design, anticancer evaluation and molecular docking targeting EGFR, VEGFR-2 and CDK-2","volume":"27","author":"El-Sayed","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119413_bib60","article-title":"New 1,2,3-triazole-coumarin-glycoside hybrids and their 1,2,4-triazolyl thioglycoside analogs targeting mitochondria apoptotic pathway: synthesis, anticancer activity and docking simulation","volume":"27","author":"El-Sayed","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119413_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400297","article-title":"Exploring novel coumarin-tethered bis-triazoles: apoptosis induction in human pancreatic cancer cells, antimicrobial effects, and molecular modelling investigations","volume":"19","author":"Dhawan","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119413_bib62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s43094-025-00821-7","article-title":"Current progress in synthetic and medicinal chemistry of pyrazole hybrids as potent anticancer agents with SAR studies","volume":"11","author":"Nehra","year":"2025","journal-title":"Future J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2026.119413_bib63","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3390\/ph15091071","article-title":"Concept of hybrid drugs and recent advancements in anticancer hybrids","volume":"15","author":"Singh","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.119413_bib64","doi-asserted-by":"crossref","first-page":"19043","DOI":"10.1039\/D1NJ02862F","article-title":"Novel coumarin-pyrazoline hybrids: synthesis, cytotoxicity evaluation and molecular dynamics study","volume":"45","author":"Ragab","year":"2021","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202200270","article-title":"Synthesis of coumarin-thiazolidine-2,4-dione-pyrazole hybrids as epidermal growth factor receptor (EGFR)-targeted agents","volume":"7","author":"Gangadhar","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2026.119413_bib66","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3897\/pharmacia.70.e108670","article-title":"Design, synthesis and molecular docking study of coumarin pyrazoline derivatives against MCF-7 breast cancer cell line","volume":"70","author":"Khalaf","year":"2023","journal-title":"Pharmacia"},{"key":"10.1016\/j.ejmech.2026.119413_bib67","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1134\/S1070363222100231","article-title":"Coumarin-pyrazole linked carbodithioates as potential anti-cancer agents: design, synthesis, biological, and molecular docking investigation","volume":"92","author":"Akki","year":"2022","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib68","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1080\/17568919.2025.2550929","article-title":"Thiazole derivatives in cancer therapy: mechanistic insights, bioactivity, and future perspective","volume":"17","author":"Saini","year":"2025","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib69","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2174\/1389557519666190308122509","article-title":"Coumarin hybrids: promising scaffolds in the treatment of breast cancer","volume":"19","author":"Bhatia","year":"2019","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib70","doi-asserted-by":"crossref","first-page":"29070","DOI":"10.1039\/D3RA03483F","article-title":"EGFR and PI3K\/m-TOR inhibitors: design, microwave assisted synthesis and anticancer activity of thiazole-coumarin hybrids","volume":"13","author":"Batran","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119413_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107682","article-title":"Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET\/STAT-3 inhibitors for potential antitumor agents","volume":"151","author":"Naguib","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib72","doi-asserted-by":"crossref","first-page":"18838","DOI":"10.1039\/D4RA02456G","article-title":"Design, synthesis, and anticancer evaluation of novel coumarin\/thiazole congeners as potential CDK2 inhibitors with molecular dynamics","volume":"14","author":"Bondock","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119413_bib73","doi-asserted-by":"crossref","first-page":"187","DOI":"10.14233\/ajchem.2023.27263","article-title":"Synthesis and anticancer activity of novel thiazolo-coumarin derivatives","volume":"35","author":"Babu","year":"2023","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib74","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2174\/0113816128346900241111115125","article-title":"Pyrimidine: a privileged scaffold for the development of anticancer agents as protein kinase inhibitors (recent update)","volume":"31","author":"Zeid","year":"2025","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2026.119413_bib75","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1007\/s11030-025-11112-x","article-title":"A review on pyrimidine-based pharmacophore as a template for the development of hybrid drugs with anticancer potential","volume":"29","author":"Sharma","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2026.119413_bib76","first-page":"202","article-title":"A review: pyrimidine-based heterocyclic hybrids as emerging anticancer chemotypes: structural innovations and therapeutic insights","volume":"12","author":"Krishnasamy","year":"2025","journal-title":"Int. J. Pharmaceut. Chem. Anal."},{"key":"10.1016\/j.ejmech.2026.119413_bib77","article-title":"Discovery of pyrimidine- and coumarin-linked hybrid molecules as inducers of JNK phosphorylation through ROS generation in breast cancer cells","volume":"28","author":"Kim","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119413_bib78","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1039\/D3MD00668A","article-title":"Coumarin-furo[2,3-d]pyrimidone hybrid molecules targeting human liver cancer cells: synthesis, anticancer effect, EGFR inhibition and molecular docking studies","volume":"15","author":"Wang","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106520","article-title":"Novel coumarin-furo[2,3-d]pyrimidinone hybrid derivatives as anticancer agents: synthesis, biological evaluation and molecular docking","volume":"188","author":"Jin","year":"2023","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2026.119413_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2026.130646","article-title":"Coumarin\u2013dihydropyrimidinone hybrids as promising agents against ovarian cancer: synthesis, SAR, and in silico evaluation","volume":"137","author":"dos Santos","year":"2026","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119413_bib81","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/0118715206272112231102063919","article-title":"Coumarin-derived hydroxamic acids as histone deacetylase inhibitors: a review of anti-cancer activities","volume":"24","author":"Khai","year":"2023","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib82","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00044-025-03509-y","article-title":"Design, synthesis and biological evaluation of novel hydroxamic acids bearing coumarin moieties as histone deacetylase inhibitors and cytotoxic agents","volume":"35","author":"Thanh","year":"2025","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2026.119413_bib83","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.3390\/molecules25215134","article-title":"Design of fluorescent coumarin-hydroxamic acid derivatives as inhibitors of HDACs: synthesis, anti-proliferative evaluation and docking studies","volume":"25","author":"Garc\u00eda","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119413_bib84","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s12964-024-01733-4","article-title":"Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy","volume":"22","author":"Zhu","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejmech.2026.119413_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136945","article-title":"Synthesis, characterization, anticancer, pharmacokinetics and molecular docking investigation of N(3)-alkyl incorporated-3-acetyl-4-hydroxycoumarin thiosemicarbazones and their copper(II) complexes","volume":"1299","author":"Shrestha","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119413_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2025.344521","article-title":"An enhancement of fluorescence and anticancer efficiency of coumarin-substituted thiosemicarbazone and its Cu2+ therapeutic sensing","volume":"1373","author":"Van Pham","year":"2025","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ejmech.2026.119413_bib87","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2025.2578183","article-title":"Harnessing coumarin-thio(seleno)cyanate conjugates: potent in vivo antiproliferative agents targeting carbonic anhydrases","volume":"40","author":"Meza-Ireta","year":"2025","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117322","article-title":"Antiproliferative activity of selenium-enriched coumarin derivatives on the SK-N-SH neuroblastoma cell line: mechanistic insights","volume":"286","author":"Wang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2026.127692","article-title":"Dual role of cyclic diselenide containing coumarin based scaffold supported with DFT\/TD-DFT studies: superoxide sensor and anti-cancer agent","volume":"355","author":"Shelar","year":"2026","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.ejmech.2026.119413_bib90","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.freeradbiomed.2011.11.034","article-title":"Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent","volume":"52","author":"Wang","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2026.119413_bib91","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/14756360410001689540","article-title":"Carbonic anhydrases: current state of the art, therapeutic applications and future prospects","volume":"19","author":"Pastorekova","year":"2004","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib92","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1021\/acsmedchemlett.5c00235","article-title":"Selective inhibition of carbonic anhydrase IX and XII by natural coumarin coladonin and its derivatives: promising antimelanoma and antiglioblastoma agents","volume":"16","author":"Mustafa","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119413_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107759","article-title":"Mitigating the resistance of MCF-7 cancer cells to doxorubicin under hypoxic conditions with novel coumarin based carbonic anhydrase IX and XII inhibitors","volume":"152","author":"Abdelaal","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.118789","article-title":"Multi-target pyrazolopyrimidine-coumarin derivatives as potent CA IX\/XII and tubulin polymerization inhibitors: design, synthesis, and biological evaluation","volume":"310","author":"Elkotamy","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib95","doi-asserted-by":"crossref","first-page":"7406","DOI":"10.1021\/acs.jmedchem.4c00239","article-title":"Discovery and mechanistic studies of dual-target hits for carbonic anhydrase IX and VEGFR 2 as potential agents for solid tumors: x ray, in vitro, in vivo, and in silico investigations of coumarin-based thiazoles","volume":"67","author":"Hefny","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111284","article-title":"Synthesis and investigation of selective human carbonic anhydrase IX, XII inhibitors using coumarins bearing a sulfonamide or biotin moiety","volume":"404","author":"Begines","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2026.119413_bib97","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.13005\/bpj\/3446","article-title":"Design and synthesis of 1,3,4-oxadiazole\u2013coumarin hybrids as EGFR inhibitors: molecular docking studies and in vitro anticancer evaluation","volume":"19","author":"Divekar","year":"2026","journal-title":"Biomed Pharmacol J"},{"key":"10.1016\/j.ejmech.2026.119413_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130444","article-title":"Coumarin\u2013benzimidazole hybrids: design, synthesis and identification of potential anticancer agents","volume":"131","author":"Arya","year":"2026","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119413_bib99","doi-asserted-by":"crossref","DOI":"10.1007\/s44371-025-00369-8","article-title":"Design, synthesis, biological evaluation and in-silico study of thioether-linked 4-hydroxycoumarin-benzothiazole derivatives targeting EGFR for cancer therapy","volume":"2","author":"Bora","year":"2025","journal-title":"Discov Chem"},{"key":"10.1016\/j.ejmech.2026.119413_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101819","article-title":"Synthesis, biological evaluation, and in silico study of novel coumarin-quinazoline analogs as potential anti-angiogenesis agents","volume":"11","author":"Emamgholipour","year":"2024","journal-title":"Results Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101959","article-title":"Novel N-quaternary coumarin-3-yl-imidazo[1,2-a]pyridines as fluorescent hybrids: their synthesis and biological evaluation in cancer cells","volume":"13","author":"Armendariz-Barrientos","year":"2025","journal-title":"Results Chem."},{"key":"10.1016\/j.ejmech.2026.119413_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116079","article-title":"Discovery of novel coumarin-based derivatives as inhibitors of tubulin polymerization targeting the colchicine binding site with potent anti-gastric cancer activities","volume":"265","author":"Tian","year":"2024","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:21:49Z","timestamp":1791832909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426008585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":102,"alternative-id":["S0223523426008585"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119413","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coumarin-based hybrid anticancer agents: Recent advances in rational design, structure\u2013activity relationships, and biological mechanisms","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119413"}}